Effect of Polyunsaturated Fatty Acids and Some Conventional Penetration Enhancers on Transdermal Delivery of Atenolol

REFERENCES

• Bronaugh R. L., Stewart R. F., Simon M. Methods for in vitro percutaneous absorption studies VII: use of excised human skin. J. Pharm. Sci. 1986; 75: 1094–1097
   PubMed Web of Science ®Google Scholar
• Cho C. W., Shin S. C. Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix. Int. J. Pharm. 2004; 287: 67–71
   PubMed Web of Science ®Google Scholar
• Clarke S. Atenolol analytical and toxicological data. Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Postmortem Material, 2nd ed., A. C. Moffat, J. V. Jackson, M. S. Moss, B. Widdop. The Pharmaceutical Press, London 1986; 362–363
   Google Scholar
• Doukas A. G., Kollias N. Transdermal drug delivery with a pressure wave. Adv. Drug Deliv. Rev. 2004; 56: 559–579
   PubMed Web of Science ®Google Scholar
• Gennaro A. R. Remington: The Science and Practice of Pharmacy, 18th ed. Mack Publishing Company, Easton, PA 1990; 900–901
   Google Scholar
• Gupta S. P., Jain S. K. Transdermal atenolol releasing system: an approach towards its development. J. Drug Target. 2006; 14: 607–613
   PubMed Web of Science ®Google Scholar
• Hadgraft J. Skin, the final frontier. Int. J. Pharm. 2001; 224: 1–18
   PubMed Web of Science ®Google Scholar
• Harrison J. E., Watkinson A. C., Green D. M., Hadgraft J., Brain K. The relative effect of Azone and Transcutol on permeant diffusivity and solubility in human stratum corneum. Pharm. Res. 1996; 13: 542–546
   PubMed Web of Science ®Google Scholar
• Heard C. M., Gallagher S. J., Harwood J., Maguire P. B. The in vitro delivery of NSAIDs across skin was in proportion to the delivery of essential fatty acids in the vehicle—evidence that solutes permeate skin associated with their solvation cages?. Int. J. Pharm. 2003; 261: 165–169
   PubMed Web of Science ®Google Scholar
• Kadir R., Stempler D., Liron Z., Cohen S. Delivery of theophylline into excised human skin from alkanoic acid solutions: a “push-pull” mechanism. J. Pharm. Sci. 1987; 76: 774–779
   PubMed Web of Science ®Google Scholar
• Kim J., Shin S. C. Controlled release of atenolol from the ethylene-vinyl acetate matrix. Int. J. Pharm. 2004; 273: 23–27
   PubMed Web of Science ®Google Scholar
• Kligman A. M., Christophers E. Preparation of isolated sheets of human stratum corneum. Arch. Dermatol. 1963; 88: 702–705
   PubMed Web of Science ®Google Scholar
• Muller R. H., Radtke M., Wissing S. A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 2002; 54: S131–155
   PubMed Web of Science ®Google Scholar
• Nanayakkara G. R., Bartlett A., Forbes B., Marriott C., Whitfield P. J., Brown M. B. The effect of unsaturated fatty acids in benzyl alcohol on the percutaneous permeation of three model penetrants. Int. J. Pharm. 2005; 301: 129–139
   PubMed Web of Science ®Google Scholar
• Puglia C., Bonina F., Trapani G., Franco M., Ricci M. Evaluation of in vitro percutaneous absorption of lorazepam and clonazepam from hydro-alcoholic gel formulations. Int. J. Pharm. 2001; 228: 79–87
   PubMed Web of Science ®Google Scholar
• Puglia C., Filosa R., Peduto A., de Caprariis P., Rizza L., Bonina F., Blasi P. Evaluation of alternative strategies to optimize ketorolac transdermal delivery. AAPS Pharm. Sci. Tech. 2006; 7: 64
   PubMed Web of Science ®Google Scholar
• Puglia C., Tropea S., Rizza L., Santagati N. A., Bonina F. In vitro percutaneous absorption studies and in vivo evaluation of anti-inflammatory activity of essential fatty acids (EFA) from fish oil extracts. Int. J. Pharm. 2005; 299: 41–48
   PubMed Web of Science ®Google Scholar
• Richards H., Thomas C. P., Bowen J. L., Heard C. M. In-vitro transcutaneous delivery of ketoprofen and polyunsaturated fatty acids from a pluronic lecithin organogel vehicle containing fish oil. J. Pharm. Pharmacol. 2006; 58: 903–908
   PubMed Web of Science ®Google Scholar
• Röpke C. D., Kaneko T. M., Rodrigues R. M., da Silva V. V., Barros S., Sawada T. C., Kato M. J., Barros S. B. Evaluation of percutaneous absorption of 4-nerolidylcathecol from four topical formulations. Int. J. Pharm. 2002; 249: 109–116
   PubMed Web of Science ®Google Scholar
• Santoyo S., Ygartua P. Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application. Eur. J. Pharm. Biopharm. 2000; 50: 245–250
   PubMed Web of Science ®Google Scholar
• Scott R. C., Walker M., Dugard P. H. A comparison of the in vitro permeability properties of human and some laboratory animal skins. Int. J. Cosm. Sci. 1986; 7: 189–194
   Google Scholar
• Siewert M., Dressman J., Brown C. K., Shah V. P. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS Pharm. Sci. Tech. 2003; 4, article 7
   PubMedGoogle Scholar
• Tanojo H., Bouwstra J. A., Junginger H. E., Bodde H. E. In vitro human skin barrier modulation by fatty acids: skin permeation and thermal analysis studies. Pharm. Res. 1997; 14: 42–49
   PubMed Web of Science ®Google Scholar
• Touitou E., Fabin B. Altered skin permeation of a highly lipophilic molecule: tetrahydrocannabinol. Int. J. Pharm. 1988a; 43: 17–22
   Web of Science ®Google Scholar
• Touitou E., Fabin B., Dany S., Almog S. Transdermal delivery of tetrahydrocannabinol. Int. J. Pharm. 1988b; 43: 9–15
   Web of Science ®Google Scholar
• Wang M. Y., Yang Y. Y., Heng P. W. Role of solvent in interactions between fatty acids-based formulations and lipids in porcine stratum corneum. J. Control. Rel. 2004; 94: 207–216
   PubMed Web of Science ®Google Scholar
• Williams A. C., Barry B. W. Penetration enhancers. Adv. Drug Deliv. Rev. 2004; 56: 603–618
   PubMed Web of Science ®Google Scholar